Atossa Therapeutics Announces Ovarian Cancer Patient has Begun Treatment with Oral Endoxifen under FDA’s Expanded Access Pathway

NEXT STORY
Cios Flow Mobile C-Arm Market Value Predicted To Reach US$ 4,676.5 Million By 2027 Covering Pre And Post COVID-19 Market Analysis: Acumen Research And Consulting
PREV STORY
Merit Medical to Present at 20th Annual Needham Healthcare Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

JHLT releases first reports of heart transplant recipients infected with COVID-19

author_avatar
NASDAQ Market News

Shield Therapeutics plc (“Shield” or the “Group”) Completion of patient enrolment in pivotal AEGIS-CKD Phase 3 study

LONDON, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Shield Therapeutics plc (LSE:STX), a specialty pharmaceutical ...

author_avatar
NASDAQ Market News

Athenex Announces Axis Therapeutics Has Entered into a MOU with the Hong Kong Polytechnic University to Set Up a Joint Research Center on Cancer Immunotherapy

BUFFALO, N.Y., July 18, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ:ATNX), a global biopharmaceutical ...

author_avatar
NASDAQ Market News